Understanding the molecular mechanism and the role of host factors in NiV neuropathogenesis is crucial for developing effective strategies to combat NVD, as well as advancements in therapeutic modalities and vaccines against NVD.
Abstract
Nipah virus (NiV) is a single-stranded negative-sense RNA virus of the genus Henipavirus, family Paramyxoviridae. The World Health Organization has declared NiV a priority pathogen with a great public health risk due to its epidemic potential and lack of sufficient countermeasures. In humans, the virus causes Nipah viral disease (NVD), characterized by acute respiratory failure and/or encephalitis. Long-term assessments of NVD survivors have revealed persistent neurological dysfunction, including encephalopathy, cerebral atrophy, hyperintensities, ocular motor palsies, and dystonia. The entry of NiV into the central nervous system (CNS) is one of the critical and less studied aspects of its pathogenesis. NiV rapidly targets the olfactory epithelial cells in the nasal turbinate and subsequently infects neurons, allowing its spread into the CNS via axonal transport. In addition, infection of immature dendritic cells has been associated with severe CNS disease, supporting a potential role of hematogenous dissemination in neuroinvasion. Overall, understanding the molecular mechanism and the role of host factors in NiV neuropathogenesis is crucial for developing effective strategies to combat NVD. The present review delves into the neuropathogenic mechanism and immunobiology of NiV infection, as well as advancements in therapeutic modalities and vaccines against NVD.
We conducted a narrative review of the literature on Nipah virus (NiV) in Asia indexed in PubMed through August 31, 2026. NiV is a highly pathogenic zoonotic paramyxovirus with pandemic potential, causing recurrent outbreaks in South and Southeast Asia since 1998, with reported case-fatality rates of approximately 40-7...
Chih-Cheng Lai, Jin-Wei Liu, P. Lee et al.· Journal of microbiology, imm...· 0 citations
Dengue virus (DENV) is classically regarded as a non-neurotropic systemic pathogen, yet severe neurological complications, most notably meningoencephalitis, are increasingly recognized. This review synthesizes the available evidence on the molecular determinants of DENV neuroinvasion and central nervous system (CNS) in...
G. Scotto, V. Fazio, S. Kazmi et al.· Journal of Molecular Patholo...· 0 citations
Nipah virus (NiV) infection is a zoonotic disease causing recurring outbreaks since 1998. Nipah virus is highly contagious, responsible for high morbidity and mortality, and has the potential to become a pandemic. World Health Organization (WHO) has put this zoonotic disease on its priority pathogen list. Nipah virus c...
Melany Intan, Velma Herwanto· Cermin Dunia Kedokteran· 0 citations
Since the emergence of the Nipah virus (NiV) in Malaysia in 1998, it has returned multiple times and continues to pose a significant threat to global public health. It is characterised by high mortality and fatality rates and increasing evidence of human-to-human transmission. The epidemiological pattern of NiV has shi...
Nancy Joon, Harsha Rawat, V. Kaushik et al.· Reviews in Medical Virology· 0 citations
It is argued that TMUV-associated neurological disease should be interpreted along a peripheral-to-CNS sequence that separates CNS access, BBB dysfunction, post-entry brain replication, neuroinflammatory amplification, and clinical disease.
Z. Ni, Zi-Cheng Zhang, Ting Zhou et al.· Frontiers in Veterinary Scie...· 0 citations
Nipah virus (NiV) is a highly pathogenic zoonotic
paramyxovirus
first identified in Malaysia during 1998–1999. The World Health Organization (WHO) has classified NiV as a priority pathogen, citing its high case fatality rate (40%-90%), documented person-to-person transmission, and the absence of licensed vaccines o...
Jun Zhan, Danzeng Deji, Chun-Li Zhong et al.· Frontiers in Public Health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.